GlaxoSmithKline (GSK)

Add to Watchlists
Create an Alert
47.53 +0.11  +0.23% NYSE Mar 2, 10:01AM BATS Real time Currency in USD

GlaxoSmithKline Enterprise Value:

137.29B for Feb. 27, 2015

View 4,000+ financial data types

View Full Chart

GlaxoSmithKline Enterprise Value Chart

Export Data
Save Image

GlaxoSmithKline Historical Enterprise Value Data

View and export this data going back to 1976. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Feb. 27, 2015 137.29B
Feb. 26, 2015 138.30B
Feb. 25, 2015 138.01B
Feb. 24, 2015 137.97B
Feb. 23, 2015 136.98B
Feb. 20, 2015 137.13B
Feb. 19, 2015 136.36B
Feb. 18, 2015 137.01B
Feb. 17, 2015 137.99B
Feb. 13, 2015 138.54B
Feb. 12, 2015 133.76B
Feb. 11, 2015 134.39B
Feb. 10, 2015 134.48B
Feb. 9, 2015 134.82B
Feb. 6, 2015 133.88B
Feb. 5, 2015 133.76B
Feb. 4, 2015 131.36B
Feb. 3, 2015 129.70B
Feb. 2, 2015 128.98B
Jan. 30, 2015 129.08B
Jan. 29, 2015 131.87B
Jan. 28, 2015 131.46B
Jan. 27, 2015 131.87B
Jan. 26, 2015 131.94B
Jan. 23, 2015 131.51B
   
Jan. 22, 2015 131.39B
Jan. 21, 2015 130.78B
Jan. 20, 2015 129.46B
Jan. 16, 2015 128.36B
Jan. 15, 2015 126.46B
Jan. 14, 2015 126.32B
Jan. 13, 2015 126.46B
Jan. 12, 2015 126.51B
Jan. 9, 2015 126.20B
Jan. 8, 2015 127.13B
Jan. 7, 2015 124.54B
Jan. 6, 2015 123.51B
Jan. 5, 2015 124.06B
Jan. 2, 2015 125.16B
Dec. 31, 2014 126.05B
Dec. 30, 2014 127.95B
Dec. 29, 2014 128.95B
Dec. 26, 2014 128.81B
Dec. 24, 2014 128.09B
Dec. 23, 2014 127.83B
Dec. 22, 2014 129.51B
Dec. 19, 2014 129.29B
Dec. 18, 2014 129.15B
Dec. 17, 2014 126.14B
Dec. 16, 2014 125.86B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Enterprise Value

Click "Learn More" below to see how YCharts calculates Enterprise Value.

Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More

Get data for
Advertisement

GSK Enterprise Value Benchmarks

Companies
AstraZeneca 90.73B
Pfizer 220.19B
Novartis 252.25B

GSK Enterprise Value Range, Past 5 Years

Minimum 98.62B May 26 2010
Maximum 160.95B Apr 29 2014
Average 132.54B

GSK Enterprise Value Excel Add-In Codes

  • Metric Code: enterprise_value
  • Latest data point: =YCP("GSK", "enterprise_value")
  • Last 5 data points: =YCS("GSK", "enterprise_value", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.